Tigress Financial restated a "buy" rating on shares of CVS Health in a report on Tuesday, December 26th.
Among 26 analysts covering CVS Health (NYSE:CVS), 19 have Buy rating, 0 Sell and 7 Hold. The stock decreased 0.89% or $0.57 during the last trading session, reaching $63.43. Drexel Morgan & owns 0.34% invested in CVS Health Corporation (NYSE:CVS) for 4,832 shs. The stock underperformed the S&P500 by 34.36%.
Filament Llc decreased its stake in Amazon Com Inc (AMZN) by 41.66% based on its latest 2017Q4 regulatory filing with the SEC. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The institutional investor held 15,295 shares of the medical and nursing services company at the end of 2017Q4, valued at $1.11M, down from 53,655 at the end of the previous reported quarter. Mark Sheptoff Financial Planning Llc who had been investing in Cvs Health Corp for a number of months, seems to be less bullish one the $64.41 billion market cap company. On Monday, November 2 the stock rating was maintained by Oppenheimer with "Outperform". Douglass Winthrop Advsr Lc reported 0.07% of its capital in CVS Health Corporation (NYSE:CVS). During the same quarter a year ago, the firm posted $1.53 earnings per share. CBS's profit will be $451.78 million for 10.61 P/E if the $1.18 EPS becomes a reality. CVS Health posted earnings per share of $1.17 during the same quarter last year, which would suggest a positive year-over-year growth rate of 19.7%.
Since February 16, 2018, it had 0 buys, and 1 insider sale for $1.42 million activity. Intrust Bank NA's holdings in CVS Health were worth $734,000 at the end of the most recent reporting period. 71% are bullish. 30 are the (NYSE:CVS)'s analyst reports since October 18, 2017 according to StockzIntelligence Inc. Retirement Systems Of Alabama has invested 0.3% in CVS Health Corporation (NYSE:CVS). Mizuho set a $95.00 price objective on shares of CVS Health and gave the company a "buy" rating in a report on Wednesday, January 24th. The firm earned "Buy" rating on Wednesday, September 2 by Zacks. As per Thursday, February 8, the company rating was maintained by Robert W. Baird. Robert W. Baird maintained the stock with "Hold" rating in Wednesday, January 17 report. On Thursday, February 8 the stock of CVS Health Corporation (NYSE:CVS) has "Buy" rating given by RBC Capital Markets. The firm earned "Buy" rating on Thursday, July 6 by Susquehanna. On Tuesday, November 21 the rating was maintained by Leerink Swann with "Buy". The rating was maintained by BMO Capital Markets with "Hold" on Sunday, February 4. On Monday, December 4 Needham maintained CVS Health Corporation (NYSE:CVS) rating. The firm has "Hold" rating by Gabelli given on Thursday, November 2. RBC Capital Markets has "Outperform" rating and $9 target. It also increased its holding in American Intl Group Inc (NYSE:AIG) by 14,231 shares in the quarter, for a total of 96,323 shares, and has risen its stake in Skyworks Solutions Inc (NASDAQ:SWKS).
Investors sentiment decreased to 0.86 in Q4 2017. Its down 0.30, from 1.88 in 2017Q3. It is negative, as 115 investors sold CVS shares while 600 reduced holdings. 122 funds opened positions while 542 raised stakes. The pharmacy operator reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.88 by $0.04. Birch Hill Advisors Limited Liability holds 0.28% or 46,821 shares. The Roffman Miller Associates Inc holds 142,641 shares with $10.34 million value, down from 151,952 last quarter. Parnassus Investments Ca accumulated 7.21M shares. Acadian Asset Limited Liability holds 0% or 9,779 shares in its portfolio. Stifel Fincl stated it has 17,606 shares. Us Bank & Trust De stated it has 1.47M shares or 0.33% of all its holdings. Veritas Asset Management LLP now owns 8,674,524 shares of the pharmacy operator's stock valued at $705,412,000 after buying an additional 235,960 shares during the period. Fayerweather Charles invested in 3.03% or 28,626 shares. Sol Management Co has invested 0.18% in CVS Health Corporation (NYSE:CVS). Eagleclaw Managment Limited Liability Company reported 32,226 shares. Tru Company Of Virginia Va holds 86,019 shares or 0.87% of its portfolio. Assetmark Inc reported 0% stake.
Since October 11, 2017, it had 0 buys, and 11 sales for $54.99 million activity. Another trade for 670 shares valued at $1.01M was sold by ALBERG TOM A. Olsavsky Brian T sold $3.42 million worth of stock. The insider Codel Franklin R sold 5,393 shares worth $292,234. Toronto Dominion Bank now owns 477,273 shares of the pharmacy operator's stock worth $34,601,000 after acquiring an additional 16,658 shares during the last quarter. Coho Limited has 2.04 million shares for 3.65% of their portfolio. The stock had a trading volume of 5,825,185 shares, compared to its average volume of 7,634,101.
Analysts await PepsiCo, Inc. (NYSE:EMR) to report earnings on May, 1. They expect $0.56 earnings per share, up 3.70% or $0.02 from last year's $0.54 per share. PEP's profit will be $1.32B for 29.37 P/E if the $0.93 EPS becomes a reality. Rench Wealth Management has 1.3% invested in CVS Health Corporation (NYSE:CVS). The company has a current ratio of 1.02, a quick ratio of 0.52 and a debt-to-equity ratio of 0.59. Its down 0.16, from 0.88 in 2017Q3.
Hedge funds have recently made changes to their positions in the stock. 280.02 million shares or 0.09% more from 279.77 million shares in 2017Q3 were reported. It also upped Nasdaq Inc (NASDAQ:NDAQ) stake by 5,774 shares and now owns 24,031 shares. Moreover, Cim Investment Mangement Inc has 0.1% invested in WageWorks, Inc. American International Group Inc. now owns 7,081,461 shares of the pharmacy operator's stock worth $513,406,000 after purchasing an additional 6,590,370 shares in the last quarter.